Form 4: ICU Medical COO Reports Stock Unit Vesting and Sales

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, reported the acquisition and subsequent tax-related disposal of common stock derived from performance-based and restricted stock units.

Summary

• Christian B. Voigtlander, Chief Operating Officer of ICU Medical Inc./DE (ICUI), reported transactions involving common stock on March 15, 2026.
• Voigtlander acquired 11,400 shares of common stock from the settlement of performance-based restricted stock units (PRSUs) granted on March 15, 2023, which were earned at 117% of target after performance certification on February 11, 2026.
• Following the PRSU settlement, 6,301 shares of common stock were disposed of at a price of $125.85 per share, likely for tax withholding purposes, leaving 44,853 shares beneficially owned.
• Voigtlander also acquired 3,248 shares of common stock from the vesting of restricted stock units (RSUs), with no purchase or exercise price.
• Subsequently, 1,795 shares of common stock were disposed of at a price of $125.85 per share, likely for tax withholding, resulting in a final beneficial ownership of 46,306 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, primarily due to the achievement of performance targets at 117% for the PRSUs, indicating strong operational execution. The subsequent sales are routine for tax purposes and do not reflect a negative sentiment from the insider.

Positives

• Performance-based restricted stock units (PRSUs) were earned at 117% of target, indicating strong company performance against set metrics.

Negatives

• A total of 8,096 shares (6,301 from PRSUs and 1,795 from RSUs) were disposed of at $125.85 per share, likely to cover tax obligations, reducing the net increase in direct ownership.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

StockSavvy.ai notes that Form 4 filings provide transparency into insider ownership changes, which are routine for executive compensation. These transactions reflect the vesting of previously granted equity awards and are common occurrences in publicly traded companies, offering insight into executive compensation structures rather than immediate operational or strategic shifts.

Stakeholder Impact

• Shareholders gain transparency into executive compensation and ownership changes, which can be a factor in assessing management alignment with shareholder interests.
• The successful vesting of performance-based awards at an above-target rate could be viewed positively by shareholders as an indicator of management's ability to meet strategic objectives.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, specifically the vesting of stock units and subsequent tax-related sales. While the achievement of performance targets at 117% is positive, these transactions do not provide new material information that would significantly alter the fundamental outlook or warrant a change in investment recommendation. The activity is expected and does not signal a shift in company strategy or financial health.

Keywords

ICU Medical, ICUI, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Performance Shares, Chief Operating Officer